Bio-Techne, a Minneapolis life sciences firm with 500,000 products, to be sold to German company for $11.3 billion

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

Germany's Merck to buy Bio-Techne for $11.3 billion

June 25 (Reuters) - Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $11.3 billion, the German science and ...

Bio-Techne jumps after Merck KGaA strikes $11.3B buyout deal

Shares of U.S. life sciences company Bio-Techne jumped more than +22% in premarket trading on Thursday after Merck KGaA agreed to acquire the company for $73 per share in cash, va ...
STAT

At BIO 2026, industry wrestled with Washington politics, and making AI work better

Biotech executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price ...
STAT

BIO 2026: AI, federal policy impacts, and general vibes

What were the vibes like at BIO 2026? STAT reporters take you inside the annual industry conference on the latest episode of ...

BIO CEO says more consistency needed in FDA review process

By Deena Beasley SAN DIEGO, June 23 (Reuters) - U.S. biotechnology industry trade group BIO worked with the Food and Drug ...
TMCnet

Wheeler Bio Launches New Website Reflecting Expansion of Capabilities, Clients Served, and a Commitment to High-Science, High-Touch Biologics Manufacturing

The redesigned website features enhanced navigation, expanded technical content, updated service descriptions, and new resources to help biotechnology companies evaluate development and manufacturing ...

Bio-Techne agrees to $11.3 billion buyout by Germany's Merck

Bio-Techne Corp, has agreed to an acquisition offer by Germany’s Merck KGaA for about $11.3 billion, the largest M&A deal ...